BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 9037375)

  • 1. The synthesis and immunogenicity of varicella-zoster virus glycoprotein E and immediate-early protein (IE62) expressed in recombinant herpes simplex virus-1.
    Lowry PW; Koropchak CM; Choi CY; Mocarski ES; Kern ER; Kinchington PR; Arvin AM
    Antiviral Res; 1997 Feb; 33(3):187-200. PubMed ID: 9037375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human T cells recognize multiple epitopes of an immediate early/tegument protein (IE62) and glycoprotein I of varicella zoster virus.
    Bergen RE; Sharp M; Sanchez A; Judd AK; Arvin AM
    Viral Immunol; 1991; 4(3):151-66. PubMed ID: 1725699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype.
    Arvin AM; Sharp M; Smith S; Koropchak CM; Diaz PS; Kinchington P; Ruyechan W; Hay J
    J Immunol; 1991 Jan; 146(1):257-64. PubMed ID: 1670603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA sequence of a simian varicella virus gene that encodes a homologue of varicella zoster virus IE62 and herpes simplex virus ICP4.
    Clarke P; Brunschwig A; Gilden DH
    Virology; 1993 Nov; 197(1):45-52. PubMed ID: 8212583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The varicella-zoster virus immediate early protein, IE62, can positively regulate its cognate promoter.
    Perera LP; Mosca JD; Sadeghi-Zadeh M; Ruyechan WT; Hay J
    Virology; 1992 Nov; 191(1):346-54. PubMed ID: 1329324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Characterization of the Serine-Rich Tract of Varicella-Zoster Virus IE62.
    Kim SK; Shakya AK; Kim S; O'Callaghan DJ
    J Virol; 2016 Jan; 90(2):959-71. PubMed ID: 26537679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional characterization of ocular-derived human alphaherpesvirus cross-reactive CD4 T cells.
    Ouwendijk WJ; Geluk A; Smits SL; Getu S; Osterhaus AD; Verjans GM
    J Immunol; 2014 Apr; 192(8):3730-9. PubMed ID: 24623134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a herpes simplex virus/varicella-zoster virus (HSV/VZV) thymidine kinase recombinant with the pathogenic potential of HSV and a drug sensitivity profile resembling that of VZV.
    Bevilacqua F; Davis-Poynter N; Worrallo J; Gower D; Collins P; Darby G
    J Gen Virol; 1995 Aug; 76 ( Pt 8)():1927-35. PubMed ID: 7636473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of immune responses to varicella zoster viral proteins induced by DNA vaccination.
    Abendroth A; Slobedman B; Springer ML; Blau HM; Arvin AM
    Antiviral Res; 1999 Dec; 44(3):179-92. PubMed ID: 10651069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunity in strain 2 guinea-pigs inoculated with vaccinia virus recombinants expressing varicella-zoster virus glycoproteins I, IV, V or the protein product of the immediate early gene 62.
    Lowry PW; Solem S; Watson BN; Koropchak CM; Thackray HM; Kinchington PR; Ruyechan WT; Ling P; Hay J; Arvin AM
    J Gen Virol; 1992 Apr; 73 ( Pt 4)():811-9. PubMed ID: 1321876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation by varicella-zoster virus (VZV) and herpes simplex virus type-1 trans-activating genes.
    Inchauspe G; Ostrove JM
    Virology; 1989 Dec; 173(2):710-4. PubMed ID: 2556849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of a recombinant varicella-zoster virus gE-IE63 fusion protein, a putative vaccine candidate against primary infection and zoster reactivation.
    Jacquet A; Haumont M; Massaer M; Garcia L; Mazzu P; Daminet V; Grégoire D; Jacobs P; Bollen A
    Vaccine; 2002 Feb; 20(11-12):1593-602. PubMed ID: 11858867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the Likelihood of Acyclovir Resistance-Associated Mutations in the Thymidine Kinase Genes of Herpes Simplex Virus 1 and Varicella-Zoster Virus.
    Fujii H; Harada S; Yoshikawa T; Yamada S; Omura N; Shibamura M; Inagaki T; Kato H; Fukushi S; Saijo M
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30858222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The varicella-zoster virus (VZV) ORF9 protein interacts with the IE62 major VZV transactivator.
    Cilloniz C; Jackson W; Grose C; Czechowski D; Hay J; Ruyechan WT
    J Virol; 2007 Jan; 81(2):761-74. PubMed ID: 17079304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of CD8+ T cell epitopes in the immediate early 62 protein (IE62) of varicella-zoster virus, and evaluation of frequency of CD8+ T cell response to IE62, by use of IE62 peptides after varicella vaccination.
    Frey CR; Sharp MA; Min AS; Schmid DS; Loparev V; Arvin AM
    J Infect Dis; 2003 Jul; 188(1):40-52. PubMed ID: 12825169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of the latency-associated immediate early protein IE63 of varicella-zoster virus by human memory T lymphocytes.
    Sadzot-Delvaux C; Kinchington PR; Debrus S; Rentier B; Arvin AM
    J Immunol; 1997 Sep; 159(6):2802-6. PubMed ID: 9300702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with recombinant varicella-zoster virus expressing herpes simplex virus type 2 glycoprotein D reduces the severity of genital herpes in guinea pigs.
    Heineman TC; Connelly BL; Bourne N; Stanberry LR; Cohen J
    J Virol; 1995 Dec; 69(12):8109-13. PubMed ID: 7494331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular distribution of the ORF4 gene product of varicella-zoster virus is influenced by the IE62 protein.
    Defechereux P; Debrus S; Baudoux L; Schoonbroodt S; Merville MP; Rentier B; Piette J
    J Gen Virol; 1996 Jul; 77 ( Pt 7)():1505-13. PubMed ID: 8757993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The varicella-zoster virus immediate-early protein IE62 is a major component of virus particles.
    Kinchington PR; Hougland JK; Arvin AM; Ruyechan WT; Hay J
    J Virol; 1992 Jan; 66(1):359-66. PubMed ID: 1309252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granzyme B Cleaves Multiple Herpes Simplex Virus 1 and Varicella-Zoster Virus (VZV) Gene Products, and VZV ORF4 Inhibits Natural Killer Cell Cytotoxicity.
    Gerada C; Steain M; Campbell TM; McSharry B; Slobedman B; Abendroth A
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.